ACM
DXCM icon

Aubrey Capital Management’s DexCom DXCM Stock Holding History

Aubrey Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-28,860
Closed -$3.58M – 67
2023
Q4 		$3.58M Sell
28,860
-600
-2% -$61.3K 1.53% 15
2023
Q3 		$2.44M Sell
29,460
-15,000
-34% -$1.69M 1.4% 17
2023
Q2 		$5.71M Sell
44,460
-3,800
-8% -$460K 3.75% 8
2023
Q1 		$5.61M Hold
48,260
– – 3.25% 9
2022
Q4 		$5.47M Sell
48,260
-3,600
-7% -$395K 4.38% 6
2022
Q3 		$4.18M Sell
51,860
-4,300
-8% -$364K 3.58% 7
2022
Q2 		$4.19M Sell
56,160
-5,600
-9% -$511K 3.37% 12
2022
Q1 		$7.9M Sell
61,760
-20,000
-24% -$2.19M 4.51% 5
2021
Q4 		$11M Hold
81,760
– – 4.28% 6
2021
Q3 		$11.2M Hold
81,760
– – 3.52% 7
2021
Q2 		$8.73M Sell
81,760
-6,000
-7% -$576K 2.54% 13
2021
Q1 		$7.89M Hold
87,760
– – 2.22% 13
2020
Q4 		$8.11M Hold
87,760
– – 2.02% 14
2020
Q3 		$9.04M Sell
87,760
-1,600
-2% -$167K 2.8% 10
2020
Q2 		$9.06M Sell
89,360
-48,000
-35% -$4.29M 4.05% 5
2020
Q1 		$9.25M Sell
137,360
-14,400
-9% -$896K 5.72% 5
2019
Q4 		$8.3M Buy
151,760
+13,600
+10% +$645K 4.7% 5
2019
Q3 		$5.15M Buy
138,160
+44,000
+47% +$1.71M 3.15% 10
2019
Q2 		$3.53M Buy
94,160
+17,156
+22% +$539K 1.68% 27
2019
Q1 		$2.29M Buy
+77,004
New +$2.71M 1.1% 32

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Aubrey Capital Management's DXCM Position: Q1 2024 in Review

Aubrey Capital Management sold out of DexCom (DXCM) in Q1 2024, closing a stake of 28,860 shares — an estimated $3.58M sold.

Aubrey Capital Management first reported a position in DXCM in Q1 2019 and held it in 20 quarters. The position peaked at $11.2M in Q3 2021. 1,034 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Aubrey Capital Management reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Aubrey Capital Management sold 28,860 DexCom shares in Q1 2024, an estimated $3.58M.
  • Aubrey Capital Management first reported a position in DexCom in Q1 2019 and held it in 20 quarters.
  • Aubrey Capital Management's DexCom position peaked at $11.2M in Q3 2021.
  • 1,034 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Aubrey Capital Management's 13F filing for Q1 2024, filed 25 Apr 2024.